首页> 外文期刊>Contraception >Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: A pilot study
【24h】

Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: A pilot study

机译:米非司酮用于药物流产当天服用依托孕酮避孕植入物的初步研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective We sought to determine satisfaction and continuation rates of the contraceptive implant when placed on the initial visit for first-trimester medical abortion. Study Design In this pilot study, we placed the implant within 15 min of mifepristone administration. We assessed satisfaction with implant placement timing, 1-year implant continuation and abortion completion. Results We enrolled 20 participants. Sixteen (80%) returned for follow-up, and all had complete abortion. At 1 year, of 16 participants contacted, 14 (87.5%) were satisfied with implant insertion timing, and 14 (87.5%) continued the implant. Conclusions Initiation of the contraceptive implant on the initial visit for medical abortion resulted in high satisfaction and continuation rates. Implications This pilot study provides important groundwork for future larger studies to assess initiation of the contraceptive implant on the day of mifepristone for medical abortion.
机译:目的我们试图确定初次妊娠流产时首次就诊时避孕植入物的满意度和持续率。研究设计在该初步研究中,我们将植入物置于米非司酮给药的15分钟内。我们评估了对植入物植入时机,一年的植入物延续和流产完成的满意度。结果我们招募了20名参与者。十六名(80%)返回进行随访,并且全部流产。在第1年,接触的16位参与者中,有14位(87.5%)对植入物的插入时机感到满意,而14位(87.5%)继续植入。结论药物流产初次就诊时开始使用避孕植入物具有较高的满意度和持续率。启示这项初步研究为未来的大型研究提供了重要的基础,以评估米非司酮在药物流产当天是否开始避孕植入。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号